Search Results1-20 of  73

  • 1 / 4
  • SASAKI YASUTSUNA ID: 9000252820965

    Articles in CiNii:1

    • The use of human tumor clonogenic assay in predicting combination effect of cisplatin plus vindesine in carcinoma of the lung. (1985)
  • SASAKI YASUTSUNA ID: 9000253208807

    Articles in CiNii:1

    • Comparative studies of pulse and continuous exposure in human tumor clonogenic assay. (1987)
  • SASAKI YASUTSUNA ID: 9000253208817

    Articles in CiNii:1

    • Antitumor activity of quinocarmycin against carcinoma of the lung in human tumor clonogenic assay. (1987)
  • SASAKI YASUTSUNA ID: 9000253214056

    Articles in CiNii:1

    • In vitro chemosensitivity patterns of carcinoma of the lung in human tumor clonogenic assay. (1986)
  • SASAKI YASUTSUNA ID: 9000255748935

    Department of Internal Medicine, National Cancer Center Hospital (1989 from CiNii)

    Articles in CiNii:1

    • Phase I study of 5-fluorouracil (5-FU) plus high-dose leucovorin (LV) in advanced non-small cell lung cancer (NSCLC) and metastatic colon cancer of the lung. (1989)
  • SASAKI YASUTSUNA ID: 9000256173411

    National Cancer Center Hospital, Department of Internal Medicine (1989 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetic study of carboplatin in comparison with cisplatin. (1989)
  • SASAKI Yasutsuna ID: 9000002972630

    Articles in CiNii:23

    • 抗がん薬の適正かつ安全な使用に向けて (2005)
    • Pharmacogenomic Factors Influencing the 5-Fluorouracil Prodrug Tegafur (2008)
    • 治験コーディネーター(CRC)の臨床試験に果たす役割 (2000)
  • SASAKI Yasutsuna ID: 9000004682917

    Division of Oncology and Hematology, National Cancer Center Hospital East (2009 from CiNii)

    Articles in CiNii:23

    • Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma (1998)
    • Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab (2001)
    • Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance (2001)
  • SASAKI Yasutsuna ID: 9000014172342

    Department of Clinical Oncology and Medical Oncology, International Medical Center, Saitama Medical University (2008 from CiNii)

    Articles in CiNii:1

    • Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients (2008)
  • SASAKI Yasutsuna ID: 9000014247623

    Division of Oncology/Hematology, National Cancer Center Hospital East (1995 from CiNii)

    Articles in CiNii:1

    • Simultaneous determination of a new anticancer agent (NB-506) and its active metabolite in human plasma and urine by high-performance liquid chromatography with ultraviolet detection (1995)
  • SASAKI Yasutsuna ID: 9000016405617

    埼玉医科大学国際医療センター・腫瘍内科 (2009 from CiNii)

    Articles in CiNii:4

    • 抗悪性腫瘍薬の臨床薬理学 (2009)
    • Summary (2008)
    • 安全ながん薬物療法と薬剤師職能 (薬剤師が担う がん薬物療法のセーフティマネジメント) -- (がん薬物療法のセーフティマネジメント) (2007)
  • SASAKI Yasutsuna ID: 9000019061372

    Department of Medical Oncology, Saitama Medical University International Medical Center (2011 from CiNii)

    Articles in CiNii:1

    • Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1^*28 and/or UGT1A1^*6 polymorphisms (2011)
  • SASAKI Yasutsuna ID: 9000019241568

    Department of Medical Oncology, International Medical Center, Saitama Medical University (2012 from CiNii)

    Articles in CiNii:1

    • Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancer (2012)
  • SASAKI Yasutsuna ID: 9000022119704

    The Division of Hematology-Oncology, National Cancer Center Hospital (1994 from CiNii)

    Articles in CiNii:1

    • Development of Pseudolymphoma of Liver Following Interferon-alpha Therapy for Chronic Hepatitis B. (1994)
  • SASAKI Yasutsuna ID: 9000253261873

    Division of Oncology/Hematology, National Cancer Center Hospital East|The First Department of Internal Medicine, Showa University School of Medicene (1997 from CiNii)

    Articles in CiNii:1

    • Developmental Therapeutics of Anticancer Agents on the Basis of Pharmacological Information: From Phase I Studies to Clinical Practice. (1997)
  • SASAKI Yasutsuna ID: 9000253262683

    National Cancer Center Hospital East (1999 from CiNii)

    Articles in CiNii:1

    • Frequenci es of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity (1999)
  • SASAKI Yasutsuna ID: 9000253262698

    Division of Oncology, Department of Medicine, National Cancer Center Hospital East (1999 from CiNii)

    Articles in CiNii:1

    • Analysis of genetic polymorphism on the promoter region of a human liver carboxylesterase gene (1999)
  • SASAKI Yasutsuna ID: 9000253263034

    Division of Oncology, National Cancer Center Hospital East (2000 from CiNii)

    Articles in CiNii:1

    • Structural organization and characterization of the regulatory element of human carboxylesterase gene (2000)
  • SASAKI Yasutsuna ID: 9000253400015

    Department of Internal Medicine, the National Cancer Center (1985 from CiNii)

    Articles in CiNii:1

    • Phase II study of cis-diamminedichloroplatinum in patients with non-small cell lung cancer. (1985)
  • SASAKI Yasutsuna ID: 9000253400157

    Department of Internal Medicine, National Cancer Center (1985 from CiNii)

    Articles in CiNii:1

    • Phase II study of vindesine in patients with non-small cell lung cancer. (1985)
  • 1 / 4
Page Top